Nanotech treatment gets boost with GSK licensing agreement
Thursday, December 17, 2009 - 18:49
in Mathematics & Economics
(PhysOrg.com) -- GlaxoSmithKline and Ann Arbor-based NanoBio Corporation announced today that they have signed an exclusive over-the-counter licensing agreement for NanoBio`s unique nanoemulsion treatment for cold sores in the United States and Canada.